Combination therapy shows superior efficacy in reducing albumin in chronic kidney disease and type 2 diabetes patients
New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to significantly greater reductions in albuminuria than either agent alone in patients with chronic kidney disease ...
Jun 5, 2025
0
22









